Search Results - "Tarnow, L"

Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial by Joergensen, C., Tarnow, L., Goetze, J. P., Rossing, P.

“…Aim To evaluate the effects of therapy with the vitamin D analogue paricalcitol on markers of cardiovascular risk and kidney function in people with Type 1…”
Get full text

Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study by Peeters, S A, Engelen, L, Buijs, J, Jorsal, A, Parving, H-H, Tarnow, L, Rossing, P, Schalkwijk, C G, Stehouwer, C D A

“…Altered regulation of extracellular matrix remodeling by matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) may contribute to…”
Get full text

Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy by Schjoedt, K.J., Rossing, K., Juhl, T.R., Boomsma, F., Tarnow, L., Rossing, P., Parving, H.H.

“…Reduction of nephrotic range albuminuria is associated with markedly improved renal and cardiovascular outcome in patients with diabetic nephropathy…”
Get full text

At least one in three people with Type 2 diabetes mellitus referred to a diabetes centre has symptomatic obstructive sleep apnoea by Storgaard, H., Mortensen, B., Almdal, T., Laub, M., Tarnow, L.

“…Aims To investigate the prevalence of symptomatic obstructive sleep apnoea in unselected patients with Type 2 diabetes referred to a tertiary diabetes clinic…”
Get full text

Effect of metformin and insulin vs. placebo and insulin on whole body composition in overweight patients with type 2 diabetes: a randomized placebo-controlled trial by Nordklint, A. K., Almdal, T.P., Vestergaard, P., Lundby-Christensen, L., Boesgaard, T.W., Breum, L., Gade-Rasmussen, B., Sneppen, S.B., Gluud, C., Hemmingsen, B., Perrild, H., Madsbad, S., Mathiesen, E.R., Tarnow, L., Thorsteinsson, B., Vestergaard, H., Lund, S.S., Eiken, P.

“…Summary Some studies indicate potential beneficial effects of metformin on body composition and bone. This trial compared metformin + insulin vs placebo +…”
Get full text

Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes by Persson, F., Rossing, P., Schjoedt, K.J., Juhl, T., Tarnow, L., Stehouwer, C.D.A., Schalkwijk, C., Boomsma, F., Frandsen, E., Parving, H.-H.

“…Inhibition of renin with an active site inhibitor, aliskiren, lowers blood pressure (BP) in diabetic patients. Here, we studied the time course of the…”
Get full text

The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial by Nordklint, A. K., Almdal, T. P., Vestergaard, P., Lundby-Christensen, L., Boesgaard, T. W., Breum, L., Gade-Rasmussen, B., Sneppen, S. B., Gluud, C., Hemmingsen, B., Jensen, T., Krarup, T., Madsbad, S., Mathiesen, E. R., Perrild, H., Tarnow, L., Thorsteinsson, B., Vestergaard, H., Lund, S. S., Eiken, P.

“…Summary Some antihyperglycemic medications have been found to affect bone metabolism. We assessed the long-term effects of metformin compared with placebo on…”
Get full text

Arterial stiffness in people with Type 2 diabetes and obstructive sleep apnoea by Hvelplund Kristiansen, M., Banghøj, A. M., Laugesen, E., Tarnow, L.

“…Aims To examine whether people with Type 2 diabetes with concurrent obstructive sleep apnoea have increased arterial stiffness as compared with people with…”
Get full text

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril by Nielsen, S. E., Schjoedt, K. J., Astrup, A. S., Tarnow, L., Lajer, M., Hansen, P. R., Parving, H.-H., Rossing, P.

“…Diabet. Med. 27, 1144–1150 (2010) Aims  Our aim was to evaluate the markers of tubulointerstitial damage, neutrophil gelatinase‐associated lipocalin (NGAL) and…”
Get full text

A phase 2a, randomized, double‐blind 28‐day study of TZP‐102 a ghrelin receptor agonist for diabetic gastroparesis by Ejskjaer, N., Wo, J. M., Esfandyari, T., Mazen Jamal, M., Dimcevski, G., Tarnow, L., Malik, R. A., Hellström, P. M., Mondou, E., Quinn, J., Rousseau, F., McCallum, R. W.

“…Background  Gastroparesis causes significant morbidity and treatment options are limited. TZP‐102 a novel, macrocyclic, selective, oral ghrelin receptor…”
Get full text

Association between severe diabetic retinopathy and lectin pathway proteins – an 18-year follow-up study with newly diagnosed type 1 diabetes patients by Holt, C.B., Hoffmann-Petersen, I.T., Hansen, T.K., Parving, H-H., Thiel, S., Hovind, P., Tarnow, L., Rossing, P., Østergaard, J.A.

Get full text

Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications by FRYSTYK, J, TAMOW, L, HANSEN, T. Krarup, PARVING, H.-H, FLYVBJERG, A

“…Low serum adiponectin (ADPN) has been associated with increased risk of cardiovascular disease (CVD) and retinopathy in patients with type 2 diabetes mellitus…”
Get full text

Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes by Tarnow, L, Gall, M.-A, Hansen, B. V, Hovind, P, Parving, H.-H

“…Aims/hypothesis Raised N-terminal pro-B-type natriuretic peptide (NT-proBNP) is associated with a poor cardiac outcome in non-diabetic populations. Elevated…”
Get full text

QT interval prolongation during spontaneous episodes of hypoglycaemia in type 1 diabetes: the impact of heart rate correction by Christensen, T. F, Tarnow, L, Randløv, J, Kristensen, L. E, Struijk, J. J, Eldrup, E, Hejlesen, O. K

“…Aims/hypothesis Prolongation of the heart rate corrected QT interval (QTc) is seen during episodes of hypoglycaemia in type 1 diabetes. We studied the…”
Get full text

Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia‐prone people with Type 1 diabetes by Kristensen, P. L., Tarnow, L., Bay, C., Nørgaard, K., Jensen, T., Parving, H.‐H., Perrild, H., Beck‐Nielsen, H., Christiansen, J. S., Thorsteinsson, B., Pedersen‐Bjergaard, U.

“…Aims To assess the difference between analogue and human insulin with regard to nocturnal glucose profiles and risk of hypoglycaemia in people with recurrent…”
Get full text

Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes by Theilade, S., Lajer, M., Jorsal, A., Tarnow, L., Parving, H.-H., Rossing, P.

“…Diabet. Med. 29, 990–994 (2012) Aims  To evaluate whether pulse pressure alone or with placental growth factor as estimates of arterial stiffness and…”
Get full text

Telomere length predicts all-cause mortality in patients with type 1 diabetes by Astrup, A. S, Tarnow, L, Jorsal, A, Lajer, M, Nzietchueng, R, Benetos, A, Rossing, P, Parving, H.-H

“…Aims/hypothesis Type 1 diabetic patients with diabetic nephropathy have increased mortality and morbidity compared with normoalbuminuric patients. Telomere…”
Get full text

Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial by Agesen, R.M, Kristensen, P.L, Beck-Nielsen, H, Nørgaard, K, Perrild, H, Christiansen, J.S, Jensen, T, Hougaard, P, Parving, H.H, Thorsteinsson, B, Tarnow, L, Pedersen-Bjergaard, U

“…Abstract Aim Insulin analogues reduce the risk of hypoglycaemia compared with human insulin in patients with type 1 diabetes (T1D) and minor hypoglycaemia…”
Get full text

Hypoglycaemia and QT interval prolongation in type 1 diabetes – bridging the gap between clamp studies and spontaneous episodes by Christensen, T.F, Cichosz, S.L, Tarnow, L, Randløv, J, Kristensen, L.E, Struijk, J.J, Eldrup, E, Hejlesen, O.K

“…Abstract Aims We propose a study design with controlled hypoglycaemia induced by subcutaneous injection of insulin and matched control episodes to bridge the…”
Get full text

Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate by SCHJOEDT, K. J, ANDERSEN, S, ROSSING, P, TARNOW, L, PARVING, H.-H

“…It has been suggested that aldosterone plays a role in the initiation and progression of renal disease independently of arterial blood pressure and plasma…”
Get full text